Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial

Insulin Detemir ◽

Controlled Trial ◽

Efficacy And Safety ◽

Once Daily ◽

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

Diabetes Care ◽

10.2337/dc11-2264 ◽

2012 ◽

Vol 35 (10) ◽

pp. 2012-2017 ◽

Cited By ~ 122

Author(s):

E. R. Mathiesen ◽

M. Hod ◽

M. Ivanisevic ◽

S. Duran Garcia ◽

L. Brondsted ◽

...

Keyword(s):

Type 1 Diabetes ◽

Pregnant Women ◽

Insulin Detemir ◽

Controlled Trial ◽

Efficacy And Safety ◽

Nph Insulin ◽

Randomized Controlled ◽

Safety Outcomes

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes

The Journal of Clinical Pharmacology ◽

10.1002/jcph.483 ◽

2015 ◽

Vol 55 (7) ◽

pp. 831-838 ◽

Cited By ~ 2

Author(s):

Yuichiro Inoue ◽

Akinobu Nakamura ◽

Yoshinobu Kondo ◽

Kumiko Hamano ◽

Shinobu Satoh ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Insulin Detemir ◽

Controlled Trial ◽

Daily Injection ◽

Once Daily ◽

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0163350 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0163350 ◽

Cited By ~ 13

Author(s):

Ajay Kumar ◽

Edward Franek ◽

Jonathan Wise ◽

Marcus Niemeyer ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Controlled Trial ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Once Daily ◽

Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

International Journal of Geriatric Psychiatry ◽

10.1002/gps.2662 ◽

2010 ◽

pp. n/a-n/a ◽

Cited By ~ 13

Author(s):

Ralf Ihl ◽

Natalia Bachinskaya ◽

Amos D. Korczyn ◽

Veronika Vakhapova ◽

Michael Tribanek ◽

...

Keyword(s):

Ginkgo Biloba ◽

Controlled Trial ◽

Ginkgo Biloba Extract ◽

Egb 761 ◽

Efficacy And Safety ◽

Once Daily ◽

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial

Arthritis & Rheumatism ◽

10.1002/art.20007 ◽

2004 ◽

Vol 50 (2) ◽

pp. 598-606 ◽

Cited By ~ 98

Author(s):

Bernard R. Rubin ◽

Robert Burton ◽

Sandra Navarra ◽

Joseph Antigua ◽

John Londoño ◽

...

Keyword(s):

Safety Profile ◽

Controlled Trial ◽

Acute Gout ◽

Efficacy And Safety ◽

Once Daily ◽

Biphasic insulin aspart-30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once-daily insulin regimens using continuous glucose monitoring

Journal of Diabetes Investigation ◽

10.1111/jdi.12747 ◽

2017 ◽

Vol 9 (3) ◽

pp. 573-578 ◽

Cited By ~ 1

Author(s):

Daisuke Tsujino ◽

Rimei Nishimura ◽

Yoshiko Onda ◽

Chiaki Seo ◽

Kiyotaka Ando ◽

...

Keyword(s):

Insulin Aspart ◽

Insulin Detemir ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glycemic Variability ◽

Once Daily ◽

Randomized Controlled ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

Diabetic Medicine ◽

10.1111/j.1464-5491.2007.02407.x ◽

2008 ◽

Vol 25 (4) ◽

pp. 442-449 ◽

Cited By ~ 102

Author(s):

P. C. Bartley ◽

M. Bogoev ◽

J. Larsen ◽

A. Philotheou

Keyword(s):

Insulin Detemir ◽

Controlled Trial ◽

Treat To Target ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Neutral Protamine Hagedorn ◽

Basal Bolus

DURATION-8 Randomized Controlled Trial 104-Week Results—Once-Weekly Exenatide (ExQW) plus Once-Daily Dapagliflozin (DAPA) vs. ExQW or DAPA Alone

Diabetes ◽

10.2337/db18-104-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 104-LB ◽

Cited By ~ 3

Author(s):

SERGE JABBOUR ◽

CRISTIAN GUJA ◽

ELISE HARDY ◽

SUDIPTA BHATTACHARYA ◽

PETER K. OHMAN ◽

...

Keyword(s):

Controlled Trial ◽

Once Daily ◽

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter